Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for infrequent episodic asthma in children
NCT00140881Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2000
- Primary completion
- Feb 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Montelukast Sodium with Placebo (2 arms). Primary endpoint: Composite unscheduled acute health care resource utilisation at 53 weeks. Started Jun 2000; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00140881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140881.